切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - GluR - Angiotensin AT2 Receptors - ErbB - Insulin Receptors

10 件产品

每页
清除全部
  1. Insulin (human) recombinant expressed in yeast
    B7407 Insulin (human) recombinant expressed in yeast
    中文名: 胰岛素
    Target: Insulin Receptors
    Summary: 内源性胰岛素受体激动剂
      ≥58.1 mg/mL
      insoluble in H2O
  2. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  3. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    中文名: 木利替尼
    Target: ErbB
    Summary: HER2/ErbB2有效抑制剂
      ≥76.9 mg/mL
      insoluble in H2O
  4. PD123319
    B2206 PD123319
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体的拮抗剂
      ≥22.4 mg/mL
      ≥104.2 mg/mL
  5. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    中文名: 沙普替尼
    Target: EGFR|ErbB
    Summary: ErbB抑制剂
      ≥23.7 mg/mL
      insoluble in H2O
  6. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    中文名: 达克替尼
    Target: ErbB
    Summary: HER抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  7. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: 有效的HER2选择性抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  8. Lapatinib
    A8218 Lapatinib
     2 Citation
    中文名: 拉帕替尼
    Target: ErbB
    Summary: EGFR/HER2抑制剂
      ≥29.05 mg/mL
      insoluble in H2O
  9. PD 123319 ditrifluoroacetate
    A3704 PD 123319 ditrifluoroacetate
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体拮抗剂
      ≥110.2 mg/mL
      ≥73.7 mg/mL
  10. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: 多靶点HDAC抑制剂
      ≥21.7 mg/mL
      insoluble in H2O

10 件产品

每页